Gentex Corporation
NASDAQ:GNTXAuto - Parts
+$0.13 today
- Market cap
- $3.97B
- Beta
- 0.79
- P/E (TTM)
- 14.1
- EPS (TTM)
- $1.81
- Dividend yield
- 1.88%
Volume 2.61M
Average 2.17M
GNTX Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Gentex CorporationNASDAQ: GNTX
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development dips below year-ago levels
Q3 FY2026 research & development of $51.57M fell 2.0% year over year, behind the +4.4% change in trailing-twelve-month research & development. Sequentially, it rose 4.7% from the prior quarter. Over 3 fiscal years it compounded at +15.1% a year.
Context
- Research & development amounted to 8.0% of revenue in FY2025, up 0.2 pp from a year earlier.
- Research & development increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -2.0% toward the trailing-twelve-month pace of +4.4%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 203.26M USD
- Year-over-year change
- +12.0%
- 4-year CAGR
- +14.6%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 203.26M | +12.0% |
| FY2024 | 2024-12-31 | 181.48M | +17.6% |
| FY2023 | 2023-12-31 | 154.36M | +15.8% |
| FY2022 | 2022-12-31 | 133.31M | +13.2% |
| FY2021 | 2021-12-31 | 117.76M | — |
Research & Development vs competitors
How GNTX compares with its peers on the latest reported figures
- GNTX's LTM Sep 2026 research & development of $205.71M is the 3rd highest of the 11 companies compared; the peer median is $0.
- Its year-over-year change of +4.4% is the 3rd highest of 8, against a peer median of -44.9%.
- Research & development amounts to 7.9% of revenue for GNTX, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $887M | +146.4% | +0.4% | 6.2% | |
| LTM Jun 2026 | $453M | +22.1% | +1.9% | 4.1% | |
| LTM Sep 2026 | $205.71M | +4.4% | +15.1% | 7.9% | |
| LTM Jun 2026 | $103M | -44.9% | -0.4% | 2.7% | |
| LTM Mar 2026 | $54.03M | -25.1% | -2.7% | 6.7% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Oct 2026 | $0 | -100.0% | +6.6% | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | -100.0% | -31.1% | — | |
| LTM Jun 2026 | $0 | -100.0% | +3.9% | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding GNTX) | $0 | -44.9% | +0.4% | 0.0% | |
Competitors are the stored peer set for GNTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.73B | 1.92B | 2.3B | 2.31B | 2.53B |
| Cost of Revenue | 1.11B | 1.31B | 1.54B | 1.54B | 1.67B |
| Gross Profit | 619.71M | 609.81M | 762.63M | 771.09M | 866.71M |
| Gross Margin | 35.8% | 31.8% | 33.2% | 33.3% | 34.2% |
| Research & Development | 117.76M | 133.31M | 154.36M | 181.48M | 203.26M |
| Selling, General & Admin | 92.16M | 106.5M | 112.54M | 121.02M | 177.87M |
| Operating Expenses | 209.93M | 239.81M | 266.9M | 311.36M | 392.77M |
| Depreciation & Amortization | 99.11M | 96.57M | 93.32M | 94.71M | 104.04M |
| EBITDA | 515.46M | 466.29M | 598.3M | 566.93M | 565.1M |
| EBITDA Margin | 29.8% | 24.3% | 26.0% | 24.5% | 22.3% |
| Operating Income | 409.78M | 370.01M | 495.73M | 459.73M | 473.94M |
| Operating Margin | 23.7% | 19.3% | 21.6% | 19.9% | 18.7% |
| Interest Income | 3.59M | 4.8M | 0 | 13.4M | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 6.57M | (283.05K) | 9.25M | 12.49M | (12.87M) |
| Income Before Tax | 416.35M | 369.72M | 504.98M | 472.21M | 461.06M |
| Pre-Tax Margin | 24.1% | 19.3% | 22.0% | 20.4% | 18.2% |
| Income Tax Expense | 55.55M | 50.97M | 76.58M | 67.73M | 76.38M |
| Net Income | 360.8M | 318.76M | 428.4M | 404.49M | 384.84M |
| Net Margin | 20.8% | 16.6% | 18.6% | 17.5% | 15.2% |
| EPS (Basic) | 1.51 | 1.36 | 1.84 | 1.77 | 1.74 |
| EPS (Diluted) | 1.50 | 1.36 | 1.84 | 1.76 | 1.74 |
| Weighted Avg Shares | 235.53M | 230.83M | 229.41M | 225.71M | 217.83M |
| Weighted Avg Shares (Diluted) | 236.6M | 231.22M | 229.72M | 226.02M | 217.85M |
Gentex Corporation
NASDAQ:GNTX
Intrinsic Alpha fair value
Locked
Current Price
$19.33
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.